Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new marker for osteoarthritis

06.08.2004


Osteoarthritis (OA) is a common, crippling age-related disease characterized by the gradual destruction of cartilage cushioning the joints. To assess cartilage erosion, doctors routinely rely on measurement of the joint space width using radiographs. To be visible on an X-ray film, however, significant cartilage degradation must have already occurred. By the time radiographs reveal destruction, the damage to the joint is usually irreversible. Due to this method’s relatively insensitive nature, it also takes at least a year or two to detect progression of damage that has been captured on radiographs.

To improve the early diagnosis and effective treatment of OA, medical researchers have turned to the promise of biochemical markers – molecules released into bodily fluids during the process of tissue turnover. Recently, researchers in the Netherlands identified a novel marker linked to both the prevalence and the progression of OA, particularly at the knee and the hip. They share their breakthrough findings in the August 2004 issue of Arthritis & Rheumatism.

Building on the analysis of cartilage metabolism, the researchers concentrated on peptide fragments of type II collagen. Since type II collagen is located almost exclusively in cartilage, a fragment – abbreviated as CTX-II – was seen as a potential marker for cartilage destruction. To determine the relationship between CTX-II and OA, researchers drew on a large, established sample: 1,235 men and women ages 55 and older enrolled in the Rotterdam Study, a long-term research effort to investigate the incidence of, and risk factors for, chronic disabling diseases. Researchers followed up with participants, whose average was 66, over a time span of six-and-a-half years.



At the study’s onset, 19 percent of the subjects had clear radiographic evidence of OA in at least one knee; 10 percent had OA in at least one hip. At baseline, urine samples from all subjects were assessed for the concentration of CTX-II. The participants were then divided into four groups for further evaluation and continued monitoring, according to their levels of CTX-II.

According to the researchers’ calculations, subjects with a CTX-II level in the highest quartile had a 4-fold increased risk of developing OA in either the knee or hip compared with subjects in the lowest quartile. During the follow-up period, confirmed by repeated radiographs, subjects with the highest concentration of CTX-II were significantly more likely to experience rapid, destructive progression of OA – 6 times more likely at the knee and 8 times more likely at the hip. The subjects with the highest CTX-II levels also had the highest complaints of joint pain. In addition, the researchers found a slight rise in CTX-II concentration with increasing age among women. However, the strong correlation between CTX-II and both the incidence and severity of OA was shown to be independent of age, sex, and body mass index.

"This is the first large follow-up study in which the use of CTX-II as a biomarker for cartilage degradation and disease progression has been investigated," emphasizes the team’s leading researcher and spokesperson, M. Reijman, MSc. "Based on the results, we conclude that the CTX-II concentration is markedly associated with the prevalence and progression of OA of the knee and hip, and that these associations are independent of known risk factors for radiographic OA. The presence of joint pain seems to augment this relationship," he notes, "which might reflect the effects of an ongoing OA process. The increase of CTX-II in women after menopause may reflect a protective effect of estrogen against cartilage loss. Further research is necessary to establish the clinical utility of this novel biomarker for OA."

David Greenberg | EurekAlert!
Further information:
http://www.wiley.com

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>